Abstract
Residues of pharmaceuticals and personal care products (PPCPs) have been detected in surface waters. Incomplete removal of these compounds by wastewater-treatment plants (WWTPs) results in their presence in effluents and finally in surface waters. The occurrence and removal of four PPCPs was investigated in three WWTPs in Mississippi, USA, during a period of 1 year. Influent and effluent were sampled from the three WWTPs. Upstream and downstream samples of the WWTPs were also collected. All four PPCPs were detected in all influents where sulfamethoxazole showed the highest concentration levels with a median concentration of 1,640 ng/L, and carbamazepine was detected at the lowest level with a median concentration of 132 ng/L. Different PPCPs were removed to different extents varying from 99 to 100 %. Gemfibrozil showed the highest removal rates (73–100 %), whereas carbamazepine showed the lowest (−99 to −30 %). Secondary activated sludge in oxidation-ditch process showed remarkable PPCP-specific removal rates. Galaxolide was removed more than the other PPCPs, and sulfamethoxazole showed the least removal. Galaxolide was found to be a predominant PPCP in effluent among the PPCPs studied, and it was detected in all downstream (14.1–428.2 ng/L) and upstream (4.1–60.0 ng/L) samples. Sulfamethoxazole was removed more during the summer than the winter season. A clear increase of PPCP concentrations was observed in most downstream samples compared with upstream samples suggesting that discharges from WWTPs are the major source of PPCPs in surface waters.
Similar content being viewed by others
References
Bartelt-Hunt SL, Snow DD, Damon T, Shockley J, Hoagland K (2009) The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environ Pollut 157:786–791
Batt AL, Kostich MS, Lazorchak JM (2008) Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC–MS/MS. Anal Chem 80:5021–5030
Bendz D, Paxeus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 122:195–204
Bruce GM, Pleus RC, Snyder SA (2010) Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol 44:5619–5626
Clara M, Gans O, Windhofer G, Krenn U, Hartl W, Braun K et al (2011) Occurrence of polycyclic musks in wastewater and receiving water bodies and fate during wastewater treatment. Chemosphere 82:1116–1123
Collard HR, Ji K, Lee S, Liu X, Kang S, Kho Y et al (2013) Toxicity and endocrine disruption in zebrafish (Danio rerio) and two freshwater invertebrates (Daphnia magna and Moina macrocopa) after chronic exposure to mefenamic acid. Ecotoxicol Environ Saf 94:80–86
Daneshvar A, Svanfelt J, Kronberg L, Prevost M, Weyhenmeyer GA (2010) Seasonal variations in the occurrence and fate of basic and neutral pharmaceuticals in a Swedish river–lake system. Chemosphere 80:301–309
Fang Y, Karnjanapiboonwong A, Chase DA, Wang J, Morse AN, Anderson TA (2012) Occurrence, fate, and persistence of gemfibrozil in water and soil. Environ Toxicol Chem 31:550–555
Gao L, Shi Y, Li W, Niu H, Liu J, Cai Y (2012) Occurrence of antibiotics in eight sewage treatment plants in Beijing, China. Chemosphere 86:665–671
Ghosh C, Shinde CP, Chakraborty BS (2012) Influence of ionization source design on matrix effects during LC–ESI–MS/MS analysis. J Chromatogr B 893–894:193–200
Grover DP, Zhou JL, Frickers PE, Readman JW (2011) Improved removal of estrogenic and pharmaceutical compounds in sewage effluent by full scale granular activated carbon: impact on receiving river water. J Hazard Mater 185:1005–1011
He YJ, Chen W, Zheng XY, Wang XN, Huang X (2013) Fate and removal of typical pharmaceuticals and personal care products by three different treatment processes. Sci Total Environ 447:248–254
Kupper T, Plagellat C, Brandli RC, de Alencastro LF, Grandjean D, Tarradellas J (2006) Fate and removal of polycyclic musks, UV filters and biocides during wastewater treatment. Water Res 40:2603–2612
Kwon JW, Armbrust KL, Vidal-Dorsch D, Bay SM, Xia K (2009) Determination of 17 alpha-ethynylestradiol, carbamazepine, diazepam, simvastatin, and oxybenzone in fish livers. J AOAC Int 92:359–369
Lee CJ, Rasmussen TJ (2006) Occurrence of organic wastewater compounds in effluent-dominated streams in Northeastern Kansas. Sci Total Environ 371:258–269
Letzel M, Metzner G, Letzel T (2009) Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input. Environ Int 35:363–368
Lin AY, Plumlee MH, Reinhard M (2006) Natural attenuation of pharmaceuticals and alkylphenol polyethoxylate metabolites during river transport: photochemical and biological transformation. Environ Toxicol Chem 25:1458–1464
Miao XS, Yang JJ, Metcalfe CD (2005) Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ Sci Technol 39:7469–7475
Mol HG, van Dam RC, Steijger OM (2003) Determination of polar organophosphorus pesticides in vegetables and fruits using liquid chromatography with tandem mass spectrometry: selection of extraction solvent. J Chromatogr A 1015:119–127
Nakada N, Shinohara H, Murata A, Kiri K, Managaki S, Sato N et al (2007) Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Res 41:4373–4382
Nassef M, Kim SG, Seki M, Kang IJ, Hano T, Shimasaki Y et al (2010a) In ovo nanoinjection of triclosan, diclofenac and carbamazepine affects embryonic development of medaka fish (Oryzias latipes). Chemosphere 79:966–973
Nassef M, Matsumoto S, Seki M, Khalil F, Kang IJ, Shimasaki Y et al (2010b) Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). Chemosphere 80:1095–1100
Parolini M, Quinn B, Binelli A, Provini A (2011) Cytotoxicity assessment of four pharmaceutical compounds on the zebra mussel (Dreissena polymorpha) haemocytes, gill and digestive gland primary cell cultures. Chemosphere 84:91–100
Radjenovic J, Petrovic M, Barcelo D (2009) Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 43:831–841
Ramirez N, Marce RM, Borrull F (2011) Development of a stir bar sorptive extraction and thermal desorption–gas chromatography–mass spectrometry method for determining synthetic musks in water samples. J Chromatogr A 1218:156–161
Reiner JL, Berset JD, Kannan K (2007) Mass flow of polycyclic musks in two wastewater treatment plants. Arch Environ Contam Toxicol 52:451–457
Rosal R, Rodriguez A, Perdigon-Melon JA, Petre A, Garcia-Calvo E, Gomez MJ et al (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 44:578–588
Santos JL, Aparicio I, Callejon M, Alonso E (2009) Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J Hazard Mater 164:1509–1516
Saravanan M, Ramesh M (2013) Short and long-term effects of clofibric acid and diclofenac on certain biochemical and ionoregulatory responses in an Indian major carp, Cirrhinus mrigala. Chemosphere 93:388–396
Segura PA, Gagnon C, Sauve S (2007) A fully automated on-line preconcentration and liquid chromatography–tandem mass spectrometry method for the analysis of anti-infectives in wastewaters. Anal Chim Acta 604:147–157
Sim WJ, Lee JW, Lee ES, Shin SK, Hwang SR, Oh JE (2011) Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 82:179–186
Snider SA (2008) Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water. Ozone Sci Eng 30:65–69
Spongberg AL, Witter JD (2008) Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci Total Environ 397:148–157
Sui Q, Huang J, Deng S, Yu G, Fan Q (2010) Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res 44:417–426
Sui Q, Huang J, Deng S, Chen W, Yu G (2011) Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes. Environ Sci Technol 45:3341–3348
Thomas PM, Foster GD (2005) Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process. Environ Toxicol Chem 24:25–30
Tong AY, Peake BM, Braund R (2011) Disposal practices for unused medications around the world. Environ Int 37:292–298
United States Environmental Protection Agency (2011) Pharmaceuticals and personal care products (PPCPs). http://epa.gov/ppcp. Accessed 14 Feb 2013
Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y (2009) Validation of bioanalytical LC–MS/MS assays: evaluation of matrix effects. J Chromatogr B 877:2198–2207
Vieno N, Tuhkanen T, Kronberg L (2007a) Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 41:1001–1012
Vieno NM, Harkki H, Tuhkanen T, Kronberg L (2007b) Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ Sci Technol 41:5077–5084
Westerhoff P, Yoon Y, Snyder S, Wert E (2005) Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 39:6649–6663
Winkler M, Headley JV, Peru KM (2000) Optimization of solid-phase microextraction for the gas chromatographic–mass spectrometric determination of synthetic musk fragrances in water samples. J Chromatogr A 903:203–210
Xu B, Mao D, Luo Y, Xu L (2011) Sulfamethoxazole biodegradation and biotransformation in the water–sediment system of a natural river. Bioresour Technol 102:7069–7076
Yan Q, Gao X, Chen Y-P, Peng X-Y, Zhang Y-X, Gan X-M et al (2014) Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area. Sci Total Environ 470–471:618–630
Yang SF, Lin CF, Lin AY, Hong PK (2011) Sorption and biodegradation of sulfonamide antibiotics by activated sludge: experimental assessment using batch data obtained under aerobic conditions. Water Res 45:3389–3397
Yu Y, Wu L (2012) Analysis of endocrine disrupting compounds, pharmaceuticals and personal care products in sewage sludge by gas chromatography–mass spectrometry. Talanta 89:258–263
Zhou JL, Zhang ZL, Banks E, Grover D, Jiang JQ (2009) Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J Hazard Mater 166:655–661
Zhou LJ, Ying GG, Liu S, Zhao JL, Yang B, Chen ZF et al (2013) Occurrence and fate of eleven classes of antibiotics in two typical wastewater treatment plants in South China. Sci Total Environ 452–453:365–376
Acknowledgments
The assistance provided by the operators of the investigated WWTPs is appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kwon, JW., Rodriguez, J.M. Occurrence and Removal of Selected Pharmaceuticals and Personal Care Products in Three Wastewater-Treatment Plants. Arch Environ Contam Toxicol 66, 538–548 (2014). https://doi.org/10.1007/s00244-013-9979-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00244-013-9979-0